NCT01461954

FST-100 in the Treatment of Acute Viral Conjunctivitis

A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 132 (actual)
• Sponsor: Shire · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.

Conditions

• Acute Viral Conjunctivitis

Interventions

Type	Name	Description
DRUG	FST-100	FST-100
DRUG	FST-100 Vehicle	FST-100 Vehicle

Timeline

• Start date: 2013-05-17
• Primary completion: 2014-03-10
• Completion: 2014-03-10
• First posted: 2011-10-28
• Last updated: 2021-06-24

Locations

2 sites across 2 countries: United States, Brazil